Voloridge Investment Management
RCUS icon

Voloridge Investment Management’s Arcus Biosciences RCUS Stock Holding History

Voloridge Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,156
Closed -$416K – 1415
2023
Q3 		$416K Buy
+23,156
New +$465K ﹤0.01% 1233
2022
Q4 		– Sell
-8,771
Closed -$229K – 1605
2022
Q3 		$229K Buy
+8,771
New +$232K ﹤0.01% 1348
2022
Q1 		– Sell
-94,938
Closed -$3.84M – 1652
2021
Q4 		$3.84M Buy
+94,938
New +$3.68M 0.02% 813
2020
Q3 		– Sell
-13,962
Closed -$345K – 1457
2020
Q2 		$345K Buy
+13,962
New +$377K ﹤0.01% 1107

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voloridge Investment Management's RCUS Position: Q4 2023 in Review

Voloridge Investment Management sold out of Arcus Biosciences (RCUS) in Q4 2023, closing a stake of 23,156 shares — an estimated $416K sold.

Voloridge Investment Management first reported a position in RCUS in Q2 2020 and held it in 4 quarters. The position peaked at $3.84M in Q4 2021. 185 funds tracked by Wall St. Rank hold RCUS as of Q4 2023.

  • Voloridge Investment Management reported no remaining Arcus Biosciences position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 23,156 Arcus Biosciences shares in Q4 2023, an estimated $416K.
  • Voloridge Investment Management first reported a position in Arcus Biosciences in Q2 2020 and held it in 4 quarters.
  • Voloridge Investment Management's Arcus Biosciences position peaked at $3.84M in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.